EdiGene Company
EdiGene is a biotechnology company that develops genome editing technologies.
Technology:
Rare Genetic Disorders
Industry:
Gene Therapy
Headquarters:
Beijing, Beijing, China
Founded Date:
2015
Funding Status:
Early Stage Venture
Estimated Revenue:
$10M to $50M
Register and Claim Ownership